{
    "Overall_score": {
        "Correlation": 7,
        "Sentiment": 6,
        "Importance": 8,
        "Impact": 7,
        "Duration": 5,
        "Virality": 4,
        "Source_Score": 9,
        "Specificity": 8,
        "Sector_Spread": 3,
        "Tech_Mentions": 2
    },
    "Each_item": [
        {
            "News_content": "Amgen Inc. (AMGN) announced positive results from a late-stage trial of its cholesterol-lowering drug, showing significant reductions in LDL levels compared to placebo.",
            "Correlation": 8,
            "Sentiment": 9,
            "Importance": 10,
            "Impact": 8,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 9,
            "Specificity": 9,
            "Sector_Spread": 4,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Analysts at J.P. Morgan downgraded Amgen's stock citing concerns over pricing pressures in the biotech sector.",
            "Correlation": 7,
            "Sentiment": 3,
            "Importance": 7,
            "Impact": 6,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 8,
            "Specificity": 7,
            "Sector_Spread": 5,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Amgen is exploring partnerships for its oncology pipeline, which could lead to expanded market opportunities.",
            "Correlation": 6,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 7,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 6,
            "Sector_Spread": 3,
            "Tech_Mentions": 1
        }
    ]
}